Gts Securities LLC Zoetis Inc. Call Options Transaction History

Gts Securities LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 13, 2024	BUY	$172.58 - $196.48 $880,158 - $1 Million	5,100 Added 82.26%	11,300 $2.21 Million
Q2 2024 Aug 14, 2024	BUY	$145.54 - $178.83 $58,216 - $71,532	400 Added 6.9%	6,200 $1.07 Million
Q1 2024 May 15, 2024	SELL	$165.67 - $199.94 $1.18 Million - $1.42 Million	-7,100 Reduced 55.04%	5,800 $981,000
Q4 2023 Feb 14, 2024	SELL	$151.44 - $200.09 $454,320 - $600,270	-3,000 Reduced 18.87%	12,900 $2.55 Million
Q3 2023 Nov 15, 2023	BUY	$167.14 - $192.77 $2.66 Million - $3.07 Million	15,900 New	15,900 $2.77 Million

1,956

412M

1.02M

1.09M

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $82B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

Get notified when there are updates to the investment portfolio of Gts Securities LLC, based on Form 13F filings with the SEC.

Stay updated on Gts Securities LLC with notifications on news.